Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Understanding Mechanism-Based, Cardiovascular Adverse Events Associated with Immune Checkpoint Blockade: Implications for Prevention and Management

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Panel Discussion
Laleh Amiri-Kordestani
FDA, Silver Spring, MD, United States
Javid M. Moslehi
Vanderbilt Univ. School of Medicine, Nashville, TN, United States
George D. Demetri
Dana-Farber Cancer Inst. and Harvard Med, Boston, MA, United States
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4